PlainRecalls
FDA Drug Moderate Class II Ongoing

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

Reported: December 25, 2024 Initiated: November 22, 2024 #D-0150-2025

Product Description

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05

Reason for Recall

Discoloration

Details

Recalling Firm
Provepharm Inc.
Units Affected
2160 packs/5 ampules per pack = 10,800 ampules
Distribution
Nationwide within the United States
Location
Collegeville, PA

Frequently Asked Questions

What product was recalled?
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05. Recalled by Provepharm Inc.. Units affected: 2160 packs/5 ampules per pack = 10,800 ampules.
Why was this product recalled?
Discoloration
Which agency issued this recall?
This recall was issued by the FDA Drug on December 25, 2024. Severity: Moderate. Recall number: D-0150-2025.